Groundbreaking Libevitug Injection Approved in China for Treating Hepatitis D Huahui Health's Libevitug injection has received conditional approval in China as a breakthrough treatment for chronic hepatitis D, addressing an urgent medical need.

Groundbreaking Libevitug Injection Approved in China for Treating Hepatitis D #China #Beijing #Hepatitis_D #Huahui_Health #Libevitug